Clinical trial
Probiotics in Patients With Primary Sclerosing Cholangitis
NCT00161148 · UMC Utrecht, Other · Unknown status
Key facts
| NCT number | NCT00161148 |
|---|---|
| Title | Probiotics in Patients With Primary Sclerosing Cholangitis |
| Official title | Probiotics in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Disease- a Randomized Placebo-Controlled Cross-Over Trial |
| Lead sponsor | UMC Utrecht, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Primary Sclerosing Cholangitis |
| Intervention type | Drug |
| Interventions | Probiotics |
| Enrollment | 12 |
| Start date | Jan 1, 2005 |
| Completion | May 1, 2006 |
| First posted | Sep 12, 2005 |
| Last update posted | Jan 9, 2007 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: